Diabetic autonomic neuropathy: What are the risks?

被引:0
|
作者
Valensi, P [1 ]
机构
[1] Hop Jean Verdier, Serv Endocrinol Diabetol Nutr, F-93143 Bondy, France
关键词
dysautonomia; diabetes; gastroparesia; unstable diabetes; neural bladder; hypoglycaemia unawareness; cardiac autonomic neuropathy; silent myocardial ischaemia; cardiac repolarisation; insulin resistance; diabetic microangiopathy;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper considers the risks related to each of the complications of diabetic autonomic neuropathy. Gastroparesia induces its own functional disorders in the digestive tract but is also probably involved in an undetermined proportion of unstable diabetes. Neural bladder, in its aspect of hypoactive, hypocontractile and hypoaesthesic bladder, makes patients prone to urinary chronic retention and repeated urinary infections or even kidney disease. In patients with hypoglycaemia unawareness, the responsibility of autonomic neuropathy may he suspected in those with severe cardiac autonomic neuropathy (CAN) or selective autonomic neuropathy characterised only by a defect in adrenergic contraregulation of hypoglycaemia. CAN is the best-known and most frequent complication of dysautonomia; Several longitudinal studies have clearly shown that CAN is associated with excessive mortality. Various functional disorders may account for the increased frequency of cardiovascular events. In particular, a reduction of left ventricle ejection fraction, inadaptability of haemodynamic response to exercise, alterations of the nycthemeral pattern of blood pressure variations, ventricle repolarisation and ventilatory function have been associated with CAN. Though the relationship between CAN and silent myocardial ischaemia is not clearly established, CAN seems to increase the frequency of major cardiac events, particularly in patients with silent myocardial ischaemia. Vascular neuropathy, by altering peripheral vasomotricity, may contribute to foot ulcer. The statistical association between CAN and retinopathy and kidney disease suggests that CAN might contribute to worsening microangiopathic complications or at least be considered as a marker of these complications. Finally, several arguments suggest an association between CAN and insulin resistance. Thus CAN might be involved in the poor prognosis of kidney disease or insulin resistance. From a practical point of view, the risks related to diabetic dysautonomia, which range from simple discomfort to severe complications, should lead to systematic detection of dysautonomia. In any event, detection by standardised tests analysing heart rate variations should he widely performed, and the presence of CAN should lead to a specific cardiovascular assessment.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [31] Detecting and treating the protean manifestations of diabetic autonomic neuropathy
    Bell, David S. H.
    DIABETES OBESITY & METABOLISM, 2023, 25 (05) : 1162 - 1173
  • [32] Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy
    Spallone, V.
    Morganti, R.
    Siampli, M.
    Fedele, T.
    D'Amato, C.
    Cacciotti, L.
    Maiello, M. R.
    DIABETIC MEDICINE, 2009, 26 (07) : 686 - 692
  • [33] Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease
    Vinik, Aaron I.
    Erbas, Tomris
    Casellini, Carolina M.
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (01) : 4 - 18
  • [34] Diabetische autonome Neuropathie: Wie erkennen, wie behandeln?Diabetic autonomic neuropathy
    Ovidiu Alin Stirban
    MMW - Fortschritte der Medizin, 2024, 166 (7) : 46 - 49
  • [35] Cardiac autonomic neuropathy: impact on severe hypoglycemic unawareness and orthostatic hypotension in diabetic dysautonomia, a case series and review
    Wu, Chaoneng
    Devireddy, Rakesh
    Zazaian, Andrew
    Kambhatla, Sujata
    Alzohaili, Opada
    Saad, Chadi
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2024, 13 (04)
  • [36] Treatment of Diabetic Cardiovascular Autonomic, Peripheral and Painful Neuropathy. Focus on the Treatment of Cardiovascular Autonomic Neuropathy with ACE Inhibitors
    Didangelos, Triantafyllos
    Veves, Aristidis
    CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (02) : 158 - 171
  • [37] The association between cardiac autonomic neuropathy and heart function in type 2 diabetic patients
    Lee, Kyung Ae
    Kim, Yu Ji
    Park, Tae Sun
    Lee, Ju Hyung
    Jin, Heung Yong
    SOMATOSENSORY AND MOTOR RESEARCH, 2020, 37 (03) : 149 - 156
  • [38] Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients
    Jung, Chan-Hee
    Kim, Bo-Yeon
    Kim, Chul-Hee
    Kang, Sung-Koo
    Jung, Sang-Hee
    Mok, Ji-Oh
    CARDIOVASCULAR DIABETOLOGY, 2012, 11
  • [39] Exhaled carbon monoxide in adolescents with diabetic cardiovascular autonomic neuropathy
    Vojtkova, Jarmila
    Durdik, Peter
    Michnova, Zuzana
    Turcan, Tomas
    Ciljakova, Miriam
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2014, 27 (7-8) : 709 - 715
  • [40] Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications
    Ayad, F.
    Belhadj, M.
    Paries, J.
    Attali, J. R.
    Valensi, P.
    DIABETIC MEDICINE, 2010, 27 (07) : 804 - 811